corticosterone has been researched along with Basal Ganglia Diseases in 1 studies
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
Excerpt | Relevance | Reference |
---|---|---|
" dosing and its effects did not show tolerance on repeated dosing." | 1.28 | Pharmacological characterization of PD 118717, a putative piperazinyl benzopyranone dopamine autoreceptor agonist. ( Christofferson, CL; Corbin, A; Demattos, S; DeWald, HA; Meltzer, LT; Myers, SL; Pugsley, TA; Shih, YH; Whetzel, SZ; Wiley, JN, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pugsley, TA | 1 |
Christofferson, CL | 1 |
Corbin, A | 1 |
DeWald, HA | 1 |
Demattos, S | 1 |
Meltzer, LT | 1 |
Myers, SL | 1 |
Shih, YH | 1 |
Whetzel, SZ | 1 |
Wiley, JN | 1 |
1 other study available for corticosterone and Basal Ganglia Diseases
Article | Year |
---|---|
Pharmacological characterization of PD 118717, a putative piperazinyl benzopyranone dopamine autoreceptor agonist.
Topics: Animals; Apomorphine; Basal Ganglia Diseases; Behavior, Animal; Cebus; Corticosterone; Coumarins; Do | 1992 |